Fasenra 30 mg solution for injection in pre-filled pen
- Name:
Fasenra 30 mg solution for injection in pre-filled pen
- Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 21/04/20

Summary of Product Characteristics last updated on medicines.ie: 21/4/2020
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. Click on this link to Download PDF directly
AstraZeneca Pharmaceuticals (Ireland) DAC
 DAC.gif)
Company Products
Items Per Page :
1 - 0 of 49 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 21 April 2020 Ed-Ptnt
Reasons for updating
- Add New Doc
Updated on 21 April 2020 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 21 April 2020 PIL
Reasons for updating
- New PIL for new product
Fasenra 30 mg solution for injection in pre-filled pen, Instructions for UseInstructions for use
(Click to Download)
Educational Materials for Medicines
Educational Materials for Medicines